Our CEO, Menzo Havenga has a hobby horse, a Clinical Development Board. It should ensure that high impact research will result in high quality products for patients. Currently in the Netherlands, the journey from paper to product is often heavily underestimated. A Clinical Development Board with experts from the early development stages to late development stages could help increase the success rate.
Read the full article (in Dutch).